Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine
#4PRI RANKED
Most Cited Paper
in Growth Hormone and Insulin-like Growth Factors
18 Months Post-Publication
Class of 2026
“Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
paltusotine · acromegaly · somatostatin receptor 2 agonist · oral treatment · somatostatin receptor ligands · Octreotide · Lanreotide · Insulin-like growth factor 1 · upper limit of normal · Acromegaly Symptom Diary · growth hormone · biochemical control · symptom control · phase 3 trial · Randomized double-blind placebo-controlled trial · treatment switching
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Growth Hormone and Insulin-like Growth Factors Papers, Class of 2026. https://pri.pepkio.com/top-papers/growth-hormone-and-insulin-like-growth-factors/2026. Accessed 2026-10-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459